Targeted treatments for cancers of the digestive system
Description: In this course I describe the faulty genes, pathways and proteins that drive colorectal, head and neck, pancreatic, oesophageal, gastric and primary liver cancer. I also explain the science behind many targeted treatment approaches for these diseases, including EGFR- and HER2-targeted antibodies, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
To book, contact: firstname.lastname@example.org or call: 020 7808 2922
View an outline of the programme